Non-small Cell Lung Cancer and Quality of Life

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non Small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with verified NSCLC
after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
Finnish speaking patients
aged 18 years or more
Written informed consent has to be signed

Exclusion criteria

Patients not consenting to participate in the study
patients not able to communicate sufficiently
cancer type is other than non-small-cell lung cancer

Sponsors and collaborators

Lead sponsor

University of Turku

Other

Registry information

Official study title

Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Acronym: SILKE

Important dates

Study start: 2008
Primary completion: 2012
Study completion: 2012
First posted: Jan 7, 2009
Registry last updated: May 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed